Stephen R. Wilson
Luna Innovations
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen R. Wilson.
Journal of Medicinal Chemistry | 2008
Darren MacFarland; Kenneth Walker; Robert P. Lenk; Stephen R. Wilson; Krishan Kumar; Christopher L. Kepley; Joel R. Garbow
Targeted imaging requires contrast agents that remain in the vasculature for extended periods of time. A new contrast agent is described in which gadolinium is encapsulated within an extremely stable carbon sphere, thus allowing for safe extended residence. Water solubility and small particle size is achieved with novel fullerene chemistry, attaching multiple oligoethylene glycol groups through nitrogen chemistry. These new compounds can be used to visualize tissue architecture in vivo with standard MRI techniques.
Bioconjugate Chemistry | 2010
Zhiguo Zhou; Robert P. Lenk; Anthony Dellinger; Stephen R. Wilson; Robert Sadler; Christopher L. Kepley
Novel amphiphilic fullerene[70] derivatives that are rationally designed to intercalate in lipid bilayers are reported, as well as its vesicular formulation with surprisingly high loading capacity up to 65% by weight. The amphiphilic C(70) bisadduct forms uniform and dimensionally stable liposomes with auxiliary natural phospholipids as demonstrated by buoyant density test, particle size distribution, and (31)P NMR. The antioxidant property of fullerenes is retained in the bipolarly functionalized C(70) derivative, amphiphilic liposomal malonylfullerene[70] (ALM), as well as in its liposomal formulations, as shown by both electron paramagnetic resonance (EPR) studies and in vitro reactive oxygen species (ROS) inhibition experiments. The liposomally formulated ALM efficiently quenched hydroxyl radicals and superoxide radicals. In addition, the fullerene liposome inhibited radical-induced lipid peroxidation and maintained the integrity of the lipid bilayer structure. This new class of liposomally formulated, amphipathic fullerene compounds represents a novel drug delivery system for fullerenes and provides a promising pathway to treat oxidative stress-related diseases.
Archive | 2006
Stephen R. Wilson
Nanomedicine: Nanotechnology, Biology and Medicine | 2009
Zhiguo Zhou; Robert P. Lenk; Anthony Dellinger; Darren MacFarland; Krishan Kumar; Stephen R. Wilson; Christopher L. Kepley
Archive | 2008
Zhiguo Zhou; Robert P. Lenk; Darren MacFarland; Kenneth Walker; Jing Zhang; Stephen R. Wilson
Archive | 2009
Christopher L. Kepley; Robert P. Lenk; Stephen R. Wilson; Zhiguo Zhou
Archive | 2008
Robert P. Lenk; Alexandru Dragos Petru Papoiu; Darren MacFarland; Stephen R. Wilson
Archive | 2006
Janice Paige Phillips; Bryan Koene; Stephen R. Wilson
Archive | 2009
Christopher L. Kepley; Robert P. Lenk; Stephen R. Wilson; Zhiguo Zhou
Archive | 2009
Christopher L. Kepley; Robert P. Lenk; Stephen R. Wilson; Zhiguo Zhou